Clearmind Medicine Inc. (CMND.CN) Research

Operating as a pre-clinical pharmaceutical firm, Clearmind Medicine Inc. specializes in pioneering psychedelic therapies aimed at addressing overlooked medical conditions. Its development efforts encompass treatments for alcohol use disorders, notably binge drinking, various eating disorders, depression, and a spectrum of mental health challenges including binge eating and other compulsive behaviors. Founded in 2017, this Vancouver, Canada-based entity transitioned from its former identity as Cyntar Ventures Inc. to Clearmind Medicine Inc. in March 2021.

Market snapshot

Symbol
CMND.CN
Price
$1.60
Day change
-12.57%
Market cap
$3.1M
P/E ratio
-0.27x
52-week range
0.0-63.9
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Asep Medical Holdings Inc (ASEP.CN)
  • Awakn Life Sciences Corp. (AWKN.NE)
  • The BC Bud Corporation (BCBC.CN)
  • Bhang Inc. (BHNG.CN)
  • Heritage Cannabis Holdings Corp. (CANN.CN)
  • 4Front Ventures Corp. (FFNT.CN)
  • GeneTether Therapeutics Inc. (GTTX.CN)
  • StageZero Life Sciences Ltd. (SZLS.TO)

Open Clearmind Medicine Inc. (CMND.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.